A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Rituximab 1000 mg i.v. will be given on day 1 and 15, week 26 - 28, together with a corticosteroid regimen consisting of methylprednisolone 100 mg i.v. 30 minutes prior to both infusions.
Epistemonikos ID: 66cf766f4c53883ace854b082b3a21dcaf2a00e3
First added on: May 04, 2024